Media Summary: Dr. Sigrún Thorsteinsdóttir, University of Iceland, presents a study on Meral Beksac, MD, Ankara University, Ankara, Turkey, discusses the emerging use of Evangelos Terpos, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, outlines findings from a study that ...
Circulating Tumor Plasma Cells In - Detailed Analysis & Overview
Dr. Sigrún Thorsteinsdóttir, University of Iceland, presents a study on Meral Beksac, MD, Ankara University, Ankara, Turkey, discusses the emerging use of Evangelos Terpos, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, outlines findings from a study that ... Rajshekhar Chakraborty, MD, Columbia University Irving Medical Center, New York City, NY, discusses the potential of Bruno Paiva, PhD from the University of Navarra, Pamplona, Spain outlines the three key reasons why myeloma Elizabeth D. Lightbody, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the value of investigating
Dr Cathelijne Fokkema talks to ecancer about her study "Newly diagnosed Multiple Myeloma patients with high levels of ... In this video, Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Health, New York City, NY, and Paola Neri, MD, PhD, ... During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Multiple Myeloma Hub spoke to ... Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, discusses the most effective method for detecting Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Health, New York City, NY, discusses the use of Stefania Oliva, MD, GIMEMA, European Myeloma Network, Italy, outlines the findings of a study of
Jesús San Miguel, MD, Universidad de Navarra, Navarra, Spain, discusses the importance of Dr. Allan, a Lawson scientist in the London Regional Cancer Program, is a national leader in the study of Speakers: Prof. Jean luc Harousseau, Prof. Bruno Paiva. Next Generation Flow Cytometry (NGFC) plays an important role in diagnostics, providing a highly sensitive method to generate ... Dr Juan-José Garcés speaks to ecancer about the abstract he presented at ASH on the mechanism of egression, clinical ... "In 2012, 13.7 million people had a history of
